禾元生物-U
(688765)
| 流通市值：28.52亿 | | | 总市值：141.68亿 |
| 流通股本：7197.09万 | | | 总股本：3.58亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 9,628,104.81 | 47,861,353.23 | 19,660,778.26 | 12,710,455.19 |
| 营业总成本 | 50,498,085.64 | 226,004,752.39 | 152,128,298.94 | 104,059,673.66 |
| 其他经营收益 | | | | |
| 营业利润 | -36,083,196.19 | -157,607,699.54 | -121,270,904.18 | -81,627,815.84 |
| 利润总额 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| 净利润 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -36,045,931.95 | -157,037,347.83 | -121,270,904.18 | -81,627,815.84 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,877,813,174.44 | 2,162,102,820.08 | 240,972,940.91 | 261,575,288.82 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,763,419,308.43 | 1,540,785,483.85 | 1,223,055,835.27 | 1,055,685,118.03 |
| 资产总计 | 3,641,232,482.87 | 3,702,888,303.93 | 1,464,028,776.18 | 1,317,260,406.85 |
| 流动负债: | | | | |
| 流动负债合计 | 566,414,471.62 | 453,597,268.05 | 376,133,296.85 | 272,793,450.11 |
| 非流动负债: | | | | |
| 非流动负债合计 | 206,214,232.88 | 351,400,011.36 | 590,945,076.63 | 513,559,820.23 |
| 负债合计 | 772,628,704.5 | 804,997,279.41 | 967,078,373.48 | 786,353,270.34 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,868,603,778.37 | 2,897,891,024.52 | 496,950,402.7 | 530,907,136.51 |
| 股东权益合计 | 2,868,603,778.37 | 2,897,891,024.52 | 496,950,402.7 | 530,907,136.51 |
| 负债和股东权益合计 | 3,641,232,482.87 | 3,702,888,303.93 | 1,464,028,776.18 | 1,317,260,406.85 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 19,294,559.97 | 154,152,435.22 | 95,436,227.65 | 67,332,319.67 |
| 经营活动现金流出小计 | 68,817,772.56 | 282,471,400.6 | 214,306,122.97 | 123,327,618.73 |
| 经营活动产生的现金流量净额 | -49,523,212.59 | -128,318,965.38 | -118,869,895.32 | -55,995,299.06 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 75,000,000 | - | - | - |
| 投资活动现金流出小计 | 233,847,042.4 | 1,848,888,635.46 | 331,602,803.67 | 268,999,470.62 |
| 投资活动产生的现金流量净额 | -158,847,042.4 | -1,848,888,635.46 | -331,602,803.67 | -268,999,470.62 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 24,900,000 | 2,868,495,138.33 | 406,587,096.13 | 314,255,951.78 |
| 筹资活动现金流出小计 | 87,246,814.67 | 382,220,746.24 | 41,676,017.48 | 17,241,801.28 |
| 筹资活动产生的现金流量净额 | -62,346,814.67 | 2,486,274,392.09 | 364,911,078.65 | 297,014,150.5 |
| 汇率变动对现金及现金等价物的影响 | 239.62 | -27,873.47 | -22,430.7 | -52,556.5 |
| 现金及现金等价物净增加额 | -270,716,830.04 | 509,038,917.78 | -85,584,051.04 | -28,033,175.68 |
| 期末现金及现金等价物余额 | 398,724,422.4 | 669,441,252.44 | 74,818,283.62 | 132,369,158.98 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 509,038,917.78 | - | -28,033,175.68 |